BioVie
BIVI
13 hedge funds and large institutions have $9.96M invested in BioVie in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
105% more capital invested
Capital invested by funds: $4.85M → $9.96M (+$5.11M)
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
30% more funds holding
Funds holding: 10 → 13 (+3)
0.05% more ownership
Funds ownership: 0.01% → 0.06% (+0.05%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KC
Kepos Capital
New York
|
+$6.7M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$5.41M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$715K |
| 4 |
Renaissance Technologies
New York
|
+$270K |
| 5 |
S
swisspartners
Vaduz,
Liechtenstein
|
+$268K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.23M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$41.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$19.3K |
| 4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$7K |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$6K |
BIVI Hedge Fund Activity: Q3 2021 in Review
13 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q3 2021, worth a combined $9.96M — up 105% from $4.85M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new BIVI positions and 3 closed out — a net gain of 3 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Kepos Capital, opening a new position worth an estimated $6.7M. The largest seller was Ameriprise, exiting entirely with an estimated $1.23M sold.
- 13 institutional investors held BioVie (BIVI) as of Q3 2021, up from 10 in Q2 2021.
- Funds reported $9.96M of BioVie stock for Q3 2021, up 105% quarter-over-quarter.
- 6 funds opened new BioVie positions in Q3 2021 and 3 closed out, a net change of +3 holders.
- The largest BioVie buyer in Q3 2021 was Kepos Capital, an estimated $6.7M added.
- The largest BioVie seller in Q3 2021 was Ameriprise, an estimated $1.23M sold.
Based on aggregated 13F filings for Q3 2021.